Tedros Adhanom Ghebreyesus & Moderna

Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, has been instrumental in declaring the public health emergency and communicating the escalating risk of the Ebola outbreak.

Moderna: Moderna received up to $50 million from CEPI to support the preclinical and early clinical development of its mRNA-based Ebola Bundibugyo vaccine candidate, leveraging its mRNA platform for rapid response.

Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, has been actively involved in the response, visiting the Democratic Republic of the Congo and calling for international support and a ceasefire to contain the outbreak. He has acknowledged the challenges and the need for community trust.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus>>>, the Director-General of the World Health Organization>>>, has declared the Ebola outbreak a public health emergency of international concern and is actively involved in coordinating the response, visiting affected areas and urging international action.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.

Tedros Adhanom Ghebreyesus: WHO Director-General, making multiple visits to DRC, urging scale-up and warning the outbreak is outpacing response. His leadership is central to global health response.

Moderna: Developed an mRNA-based Bundibugyo vaccine candidate, with Phase 1 trials starting in Canada. Its mRNA platform could offer a rapid response to emerging outbreaks.

Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, provided updates on the investigation, confirmed cases, and the financial support allocated for the response.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Tedros Adhanom Ghebreyesus: As WHO Director-General, he declared the outbreak a global emergency, raising international awareness and mobilizing resources.

Moderna: Authorized to begin Phase 1 trials for a Bundibugyo vaccine, using mRNA technology. Potential for significant revenue if successful.